November 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
The exosome diagnostic and therapeutic market focuses on innovative research for diagnosing health disorders and monitoring treatments. Exosomes, found in body fluids, are used in cancer therapy, immune modulation, and drug delivery. Companies like Capricor Therapeutics advance exosome-based treatments....
November 01, 2025
Cervical cancer is caused by HPV infections and diagnosed through tests like Pap tests, HPV tests, biopsies, and imaging. Regular screenings and advancements in diagnostic techniques are driving market growth. Initiatives like the WHO’s Global Strategy and investments, such as DNA Wellness' 100 labs, are boosting awareness and detection effor...
November 01, 2025
The medical imaging reagents market includes various agents used in diagnostic techniques like MRI, X-ray, and PET. These reagents help in detecting diseases, monitoring cellular functions, and improving early diagnosis. Companies like Siemens Healthineers and GE Healthcare are advancing imaging technologies, with AI enhancing accuracy and efficien...
November 01, 2025
Organ-on-a-chip (OoC) systems use tiny tissues in microfluidic chips to mimic human physiology. By improving drug development, accuracy, and cost efficiency, OoCs offer a more precise alternative to animal models. The FDA’s 2022 act supports using non-animal data for clinical trials, advancing research....
November 01, 2025
According to market projections, the global spectrometry market, valued at USD 20.41 billion in 2024, is anticipated to reach USD 43.93 billion by 2034, growing at a CAGR of 7.97% over the next decade. The growing research and development, increasing investments & collaborations, and the rising prevalence of chronic disorders drive the market....
November 01, 2025
The molecular cytogenetics market is growing due to the rising demand for cancer diagnosis, congenital syndrome detection, and personalized medicine. Key drivers include advances in genomics, increasing R&D, and government investments. Notable industry movements include new lab openings and acquisitions in diagnostic services....
November 01, 2025
The early toxicity testing market is expanding rapidly, driven by its role in safety evaluation, environmental remediation, and green chemistry initiatives. Innovations like in vitro methods, the FDA's 3Rs Alternatives Program, and ToxCast data advances are reducing animal testing and streamlining drug development....
November 01, 2025
According to market projections, the oncology NGS sector is expected to grow from USD 508.95 million in 2024 to USD 2,193.49 million by 2034, reflecting a CAGR of 15.73%. The demand for NGS in oncology is high due to growing cases of cancer and R&D for new treatments and diagnoses....
November 01, 2025
According to market projections, the glycomics sector is expected to grow from USD 2.21 billion in 2024 to USD 8.66 billion by 2034, reflecting a CAGR of 14.64%. The glycomics field is growing significantly due to its applications in drug discovery, disease diagnosis, therapeutics, and personalized medicine....
November 01, 2025
Single-use pumps are revolutionizing biopharmaceutical production by cutting costs and downtime. These pumps eliminate cleaning needs, reduce contamination risks, and ensure consistent pressure and flow. Ideal for handling large molecules, they streamline drug production with efficiency and reliability....